PuSH - HMGU Publikationen https://push-zb.helmholtz-munich.de PuSH - Publikationen-Server des Helmholtz Zentrums München de-de <![CDATA[Scholz, S.* et al. The cost-of-illness for invasive meningococcal disease caused by serogroup B Neisseria meningitidis (MenB) in Germany. Vaccine 37, 1692-1701 (2019)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=55306&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=55306&la=de Mon, 11 Mar 2019 00:00:00 +0000 <![CDATA[Ghasemi, A.* et al. Immunization with a recombinant fusion protein protects mice against Helicobacter pylori infection. Vaccine 36, 5124-5132 (2018)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=54000&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=54000&la=de Fri, 27 Jul 2018 00:00:00 +0000 <![CDATA[Beyerlein, A. et al. Vaccinations in early life are not associated with development of islet autoimmunity in type 1 diabetes high-risk children: Results from prospective cohort data. Vaccine 35, 1735-1741 (2017)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=50611&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=50611&la=de Fri, 07 Apr 2017 00:00:00 +0000 <![CDATA[Link, E.K.* et al. A synthetic human cytomegalovirus pp65-IE1 fusion antigen efficiently induces and expands virus specific T cells. Vaccine 35, 5131-5139 (2017)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=51733&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=51733&la=de Mon, 18 Sep 2017 00:00:00 +0000 <![CDATA[Backes, S. et al. Protein-prime/modified vaccinia virus Ankara vector-boost vaccination overcomes tolerance in high-antigenemic HBV-transgenic mice. Vaccine 34, 923-932 (2016)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=47704&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=47704&la=de Wed, 20 Jan 2016 00:00:00 +0000 <![CDATA[Ghasemi, A.* ; Jeddi-Tehrani, M.* ; Mautner, J. ; Salari, M.H.* & Zarnani, A.H.* Simultaneous immunization of mice with Omp31 and TF provides protection against Brucella melitensis infection. Vaccine 33, 5532-5538 (2015)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=46970&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=46970&la=de Tue, 13 Oct 2015 00:00:00 +0000 <![CDATA[Ghasemi, A.* ; Jeddi-Tehrani, M.* ; Mautner, J. ; Salari, M.H.* & Zarnani, A.H.* Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection. Vaccine 32, 6659-6666 (2014)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=32346&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=32346&la=de Wed, 24 Sep 2014 00:00:00 +0000 <![CDATA[von Sonnenburg, F.* et al. Safety and immunogenicity of modified vaccinia Ankara as a smallpox vaccine in people with atopic dermatitis. Vaccine 32, 5696-5702 (2014)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=31999&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=31999&la=de Wed, 27 Aug 2014 00:00:00 +0000 <![CDATA[Buchmann, P.* et al. A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in Hepatitis B Virus (HBV) transgenic mice. Vaccine 31, 1197-1203 (2013)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=23526&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=23526&la=de Thu, 21 Mar 2013 00:00:00 +0000 <![CDATA[Farag, M.M.S.* et al. Immune tolerance against HBV can be overcome in HBV transgenic mice by immunization with dendritic cells pulsed by HBVsvp. Vaccine 30, 6034-6039 (2012)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=10627&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=10627&la=de Fri, 26 Oct 2012 00:00:00 +0000 <![CDATA[Schlosser, E.* et al. TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses. Vaccine 26, 1626-1637 (2008)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=4895&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=4895&la=de Wed, 10 Sep 2008 00:00:00 +0000 <![CDATA[Schulze, K.* et al. A prime-boost vaccination protocol optimizes immune responses against the nucleocapsid protein of the SARS coronavirus. Vaccine 26, 6678-6684 (2008)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=3003&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=3003&la=de Wed, 31 Dec 2008 00:00:00 +0000 <![CDATA[Antonis, A.F.G.* et al. Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge. Vaccine 25, 4818-4827 (2007)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=5558&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=5558&la=de Mon, 31 Dec 2007 00:00:00 +0000 <![CDATA[El-Gogo, S.* et al. Recombinant murine gammaherpesvirus 68 (MHV-68) as challenge virus to test efficacy of vaccination against chronic virus infections in the mouse model. Vaccine 25, 3934-3945 (2007)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=4182&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=4182&la=de Wed, 16 May 2007 00:00:00 +0000 <![CDATA[Meyer, P. et al. Inhalative vaccination with pneumococcal polysaccharide in patients with chronic obstructive pulmonary disease. Vaccine 24, 5832-5838 (2006)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=4936&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=4936&la=de Mon, 16 Oct 2006 00:00:00 +0000 <![CDATA[Menzel, M.* ; Muellinger, B.* ; Weber, N. ; Häussinger, K. & Ziegler-Heitbrock, L. Inhalative vaccination with pneumococcal polysaccharide in healthy volunteers. Vaccine 23, 5113-5119 (2005)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=1004&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=1004&la=de Wed, 14 Dec 2005 00:00:00 +0000 <![CDATA[Olszewska, W.* ; Suezer, Y. & Openshaw, P.J.M.* Protective and disease-enhancing immune responses induced by recombinant modified vaccinia Ankara (MVA) expressing respiratory syncytial virus proteins. Vaccine 23, 215-221 (2004)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=3045&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=3045&la=de Fri, 31 Dec 2004 00:00:00 +0000 <![CDATA[Welte, R. et al. Economic evaluation of meningococcal serogroup C conjugate vaccination programmes in The Netherlands and its impact on decision-making. Vaccine 23, 470-479 (2004)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=1873&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=1873&la=de Mon, 21 Mar 2005 00:00:00 +0000 <![CDATA[Cosma, A. et al. Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals. Vaccine 22, 21-29 (2003)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=9504&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=9504&la=de Wed, 29 Oct 2003 00:00:00 +0000 <![CDATA[Stittelaar, K.J.* et al. Comparison of the efficacy of early versus late viral proteins in vaccination against SIV. Vaccine 20, 2921-2927 (2002)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=21990&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=21990&la=de Fri, 22 Nov 2002 00:00:00 +0000 <![CDATA[Nilsson, C.* et al. Enhanced simian immunodeficiency virus-specific immune responses in macaques induced by priming with recombinant Semliki Forest virus and boosting with modified vaccinia virus Ankara. Vaccine 19, 3526-3536 (2001)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=21903&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=21903&la=de Wed, 19 Jun 2002 00:00:00 +0000 <![CDATA[Collings, A.* et al. Humoral and cellular immune responses to HIV-1 Nev in mice DNA-immunised with non- replicating or self-replicating expression vectors. Vaccine 18, 460-467 (2000)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=21298&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=21298&la=de Sun, 31 Dec 2000 00:00:00 +0000 <![CDATA[Osterhaus, A.D.* et al. Vaccination with Rev and Tat against AIDS. Vaccine 17, 2713-2714 (1999)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=21297&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=21297&la=de Fri, 31 Dec 1999 00:00:00 +0000 <![CDATA[von Brunn, A. et al. The Principal Neutralizing Determinant (V3) of HIV-1 Induces HIV-1-neutralizing Antibodies upon Expression on HBcAg Particles. Vaccine 93 (1993)]]> https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=20460&la=de https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=20460&la=de Fri, 31 Dec 1993 00:00:00 +0000